Sixi Zhang

485 total citations
16 papers, 402 citations indexed

About

Sixi Zhang is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Complementary and alternative medicine. According to data from OpenAlex, Sixi Zhang has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Complementary and alternative medicine. Recurrent topics in Sixi Zhang's work include Traditional Chinese Medicine Analysis (5 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Inflammasome and immune disorders (3 papers). Sixi Zhang is often cited by papers focused on Traditional Chinese Medicine Analysis (5 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Inflammasome and immune disorders (3 papers). Sixi Zhang collaborates with scholars based in China. Sixi Zhang's co-authors include Lina Tao, Xiaoyu Qu, Huan Gao, Jinghui Zhai, Yueming Zhang, Yanqing Song, Jingmeng Sun, Yue Zhang, Tingting Hu and Jianyuan Yin and has published in prestigious journals such as Phytotherapy Research, Chemico-Biological Interactions and Biological and Pharmaceutical Bulletin.

In The Last Decade

Sixi Zhang

15 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sixi Zhang China	11	166	79	78	69	56	16	402
Jingmeng Sun China	12	211 1.3×	93 1.2×	76 1.0×	63 0.9×	52 0.9×	18	456
Lan Yao China	14	208 1.3×	34 0.4×	72 0.9×	26 0.4×	38 0.7×	39	524
Man Luo China	13	322 1.9×	54 0.7×	45 0.6×	29 0.4×	31 0.6×	20	541
Enchao Zhou China	12	204 1.2×	50 0.6×	37 0.5×	44 0.6×	28 0.5×	25	487
Bingbing Zhu China	14	238 1.4×	46 0.6×	44 0.6×	48 0.7×	36 0.6×	50	609
Meng Lu China	10	270 1.6×	29 0.4×	86 1.1×	39 0.6×	56 1.0×	18	523
Rania R. Abdеlaziz Egypt	13	143 0.9×	72 0.9×	61 0.8×	24 0.3×	30 0.5×	35	426
Fujing Wang China	11	165 1.0×	38 0.5×	59 0.8×	49 0.7×	54 1.0×	24	381
Cengiz Koçak Türkiye	14	135 0.8×	65 0.8×	54 0.7×	43 0.6×	31 0.6×	40	410
Xiaojuan Ma China	13	180 1.1×	43 0.5×	46 0.6×	100 1.4×	29 0.5×	38	460

Countries citing papers authored by Sixi Zhang

Since Specialization

Citations

This map shows the geographic impact of Sixi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixi Zhang more than expected).

Fields of papers citing papers by Sixi Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixi Zhang. The network helps show where Sixi Zhang may publish in the future.

Co-authorship network of co-authors of Sixi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Sixi Zhang. A scholar is included among the top collaborators of Sixi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sixi Zhang. Sixi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhang, Yueming, Nan Li, Lina Tao, et al.. (2025). Potential role of SIRT1 in cell ferroptosis. Frontiers in Cell and Developmental Biology. 13. 1525294–1525294. 4 indexed citations

Zhang, Yueming, et al.. (2025). The role of SIRT1 in the development of gastrointestinal tumors. Frontiers in Cell and Developmental Biology. 13. 1606530–1606530. 1 indexed citations

Zhai, Jinghui, et al.. (2025). The role of gut microbiota dysbiosis in drug-induced brain injury: mechanisms and therapeutic implications. Frontiers in Cell and Developmental Biology. 13. 1604539–1604539.

Zhai, Jinghui, Huan Gao, Shuo Wang, et al.. (2021). Ginsenoside Rg3 attenuates cisplatin‐induced kidney injury through inhibition of apoptosis and autophagy‐inhibited NLRP3. Journal of Biochemical and Molecular Toxicology. 35(11). e22896–e22896. 19 indexed citations

Qu, Xiaoyu, Yueming Zhang, Lina Tao, et al.. (2019). XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression. Chinese Journal of Natural Medicines. 17(7). 498–505. 22 indexed citations

Qu, Xiaoyu, Huan Gao, Lina Tao, et al.. (2019). Astragaloside IV protects against cisplatin-induced liver and kidney injury via autophagy-mediated inhibition of NLRP3 in rats. The Journal of Toxicological Sciences. 44(3). 167–175. 71 indexed citations

Zhang, Yueming, Xiaoyu Qu, Lina Tao, et al.. (2019). XingNaoJing injection ameliorates cerebral ischaemia/reperfusion injury via SIRT1-mediated inflammatory response inhibition. Pharmaceutical Biology. 58(1). 16–24. 36 indexed citations

Tao, Lina, Xiaoyu Qu, Yue Zhang, Yanqing Song, & Sixi Zhang. (2019). Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials. Canadian Journal of Gastroenterology and Hepatology. 2019. 1–11. 33 indexed citations

Zhai, Jinghui, Lina Tao, Yueming Zhang, et al.. (2019). Salvianolic Acid B Attenuates Apoptosis of HUVEC Cells Treated with High Glucose or High Fat via Sirt1 Activation. Evidence-based Complementary and Alternative Medicine. 2019. 1–11. 16 indexed citations

10.

Zhai, Jinghui, Lina Tao, Sixi Zhang, et al.. (2019). Calycosin ameliorates doxorubicin‐induced cardiotoxicity by suppressing oxidative stress and inflammation via the sirtuin 1–NOD‐like receptor protein 3 pathway. Phytotherapy Research. 34(3). 649–659. 75 indexed citations

11.

Gao, Huan, Sixi Zhang, Tingting Hu, et al.. (2018). Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells. Chemico-Biological Interactions. 297. 130–140. 36 indexed citations

12.

Zhang, Yueming, Xiaoyu Qu, Jinghui Zhai, et al.. (2018). Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt‐Mediated eNOS Phosphorylation. Evidence-based Complementary and Alternative Medicine. 2018(1). 2361046–2361046. 27 indexed citations

13.

Qu, Xiaoyu, Jinghui Zhai, Tingting Hu, et al.. (2018). Dioscorea bulbifera L. delays the excretion of doxorubicin and aggravates doxorubicin-induced cardiotoxicity and nephrotoxicity by inhibiting the expression of P-glycoprotein in mice liver and kidney. Xenobiotica. 49(9). 1116–1125. 12 indexed citations

14.

Zhai, Jinghui, Xiaoyu Qu, Yueming Zhang, et al.. (2018). Salvianolic acid inhibits the effects of high glucose on vascular endothelial dysfunction by modulating the Sirt1‐eNOS pathway. Journal of Biochemical and Molecular Toxicology. 33(2). e22245–e22245. 7 indexed citations

15.

Qu, Xiaoyu, Huan Gao, Lina Tao, et al.. (2018). Autophagy inhibition‐enhanced assembly of the NLRP3 inflammasome is associated with cisplatin‐induced acute injury to the liver and kidneys in rats. Journal of Biochemical and Molecular Toxicology. 33(1). e22208–e22208. 35 indexed citations

16.

Song, Yanqing, Huan Gao, Sixi Zhang, et al.. (2017). Prescription Optimization and Oral Bioavailability Study of Salvianolic Acid Extracts W/O/W Multiple Emulsion. Biological and Pharmaceutical Bulletin. 40(12). 2081–2087. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact